Platelets activation and indices in patients with systemic lupus | ||||
| Al-Azhar University Journal of Virus Researches and Studies | ||||
| Article 6, Volume 3, Issue 1, 2021, Page 1-14 PDF (497.46 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/aujv.2021.207067 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| Systemic lupus erythematosus (SLE) is an autoimmune disease with higher prevalence in women than men, with a female-to-male ratio ranging from 8:1 to 15:1.SLE is characterized by periods of remission and exacerbation (flares) with prolonged periods of subclinical activity, thus making it a very unpredictable disease needs continuous assessment of disease activity. There is no single biomarker used for that purpose. Platelet activation markers as CD62p and Platelet indices have recently been found to be a simple inflammatory marker used in the assessment of systemic inflammation in many diseases like rheumatoid arthritis, ankylosing spondylitis and, inflammatory bowel diseases. Aim of study, to investigate the platelet indices and their relation to platelet activation and disease activity in SLE patients. A case-control study enrolled forty SLE recruited from AL-Zahraa University Hospital Al- Azhar University. According to Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score the patients were divided into three groups first one including ten patients without flare (SELEDAI <4), a second group including ten patients moderate flare (SELEDAI 8 – <12) and the third group including twenty patients with severe flare (SELEDAI >or=12). Another forty persons apparently healthy including in the study as a control group. P selectin and Platelet indices (MPV, PDW, PTC) were assessed in all of them and their correlation to the SLEDAI score was analyzed. There was a highly significant increase in P selectin in the active patients more than non-active patients (p-value < 0.05) and a highly significant increase in severe activity compared to moderate activity (p-value < 0.001), and a significant decrease in PCT and MPV in the active patients less than non- active patients (p-value < 0.05) and it is decreased in severe cases compared to moderate activity, non-active and control groups(p-value < 0.05 ) and it had a significant negative correlation with SELEDAI score. By Using the ROC curve, it was shown that MPV can be used to discriminate between active & non-active SLE patients with a specificity of 66.7% and sensitivity 60%. Also, CD62p can be used to discriminate between active & non-active SLE patients with 66.7% sensitivity & 80% specificity. P selectin, mean platelet volume (MPV), and Plateletcrit (PCT) could be used as a novel marker for SLE activity. | ||||
| Keywords | ||||
| SLE; Lupus activity; SLEDAI; p selectin-Platelet indices; Mean platelet volume; Platelet-crit; Platelet distribution width | ||||
|
Statistics Article View: 97 PDF Download: 122 |
||||
